Michael Greiner Avanos Medical, Inc. (AVNS) insider trading activity

Michael Greiner is Interim CEO of AVANOS MEDICAL, INC.. Currently has a direct ownership of 224,264 shares of AVNS, which is worth approximately $3.13 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 34,316 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

11.63% 3M change

52.86% 12M change

Total Value Held $3.13 Million

Michael Greiner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2025	BUY Grant, award, or other acquisition	-	34,316 Added 13.27%	224,264 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$208,034 $15.3 p/Share	13,597 Reduced 6.68%	189,948 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$161,739 $15.13 p/Share	10,690 Reduced 4.99%	203,545 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	12,149 Added 5.37%	214,235 Common Stock
Dec 03 2024	BUY Grant, award, or other acquisition	-	10,000 Added 4.74%	200,898 Common Stock
Oct 29 2024	BUY Grant, award, or other acquisition	-	44,189 Added 18.8%	190,898 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$171,905 $19.09 p/Share	9,005 Reduced 5.78%	146,709 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	-	4,219 Added 2.64%	155,714 Common Stock
Mar 14 2024	SELL Open market or private sale	$153,120 $19.14 p/Share	8,000 Reduced 5.02%	151,495 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$97,242 $19.0 p/Share	5,118 Reduced 3.11%	159,495 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	$1,099,994 $19.14 p/Share	57,471 Added 25.88%	164,613 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$93,631 $18.76 p/Share	4,991 Reduced 4.48%	106,312 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$352,598 $23.97 p/Share	14,710 Reduced 11.67%	111,303 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$89,955 $29.62 p/Share	3,037 Reduced 2.32%	127,744 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	36,350 Added 21.75%	130,781 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$127,885 $27.06 p/Share	4,726 Reduced 4.8%	93,765 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	30,575 Added 23.69%	98,491 Common Stock
Mar 17 2021	BUY Grant, award, or other acquisition	$750,067 $47.29 p/Share	15,861 Added 19.09%	67,244 Common Stock

Michael Greiner

Interim CEO

Alpharetta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVNS shares.

Notify only if

Value

Insider Trading

Get notified when an Avanos Medical, Inc. insider buys or sells AVNS shares.

Notify only if

Operation

Value

Type

News

Receive news related to AVANOS MEDICAL, INC.

Track Activities on AVNS

Account